Publication | Closed Access
α-Blocker and Risk of Dementia in Patients with Benign Prostatic Hyperplasia: A Nationwide Population Based Study Using the National Health Insurance Service Database
36
Citations
0
References
2019
Year
The study findings indicate that benign prostatic hyperplasia medication is not associated with a risk of dementia by duration of use or by type.